Sign in

William Velmer

Research Analyst at S.A. Advisory

William Velmer is the Editor of S.A. Advisory, specializing in investment newsletters and corporate analysis with a track record of publishing market commentary continuously since 1984. Over his career, he has covered a wide range of small-cap and emerging companies across various sectors, offering detailed profiles and investment guidance. While specific performance statistics and company coverage lists are not publicly disclosed, Velmer is recognized for his longevity and deep knowledge of market news, drawing on decades of experience in financial publishing. His professional credentials and securities licenses are not indicated in public records, reflecting a background centered on independent market analysis and publishing rather than FINRA-registered securities brokerage.

William Velmer's questions to BLONDER TONGUE LABORATORIES (BDRL) leadership

Question · Q3 2022

William Velmer of S.A. Advisory asked about Blonder Tongue's path to profitability, questioning how the company plans to stop losing money despite revenue growth. He also inquired if the company has been approached for a merger or acquisition, given its cutting-edge technology.

Answer

CEO Ted Grauch acknowledged the performance issues, attributing them to semiconductor supply chain costs and allocation limits over the past year. He noted that these headwinds are stabilizing and that demand for high-margin products remains strong. While declining to give specific 2023 guidance, he expressed optimism. Regarding strategic alternatives, Grauch confirmed that the company is open to and actively in discussions with other companies about potential mergers or acquisitions to maximize shareholder value.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts